Persistent URL of this record https://hdl.handle.net/1887/3249506
In Collections
This item can be found in the following collections:
![Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
- All authors
- Schreuder, F.H.B.M.; Nieuwenhuizen, K.M. van; Hofmeijer, J.; Vermeer, S.E.; Kerkhoff, H.; Zock, E.; Luijckx, G.J.; Messchendorp, G.P.; Tuijl, J. van; Bienfait, H.P.; Booij, S.J.; Wijngaard, I.R. van den; Remmers, M.J.M.; Schreuder, A.H.C.M.L.; Dippel, D.W.; Staals, J.; Brouwers, P.J.A.M.; Wermer, M.J.H.; Coutinho, J.M.; Kwa, V.I.H.; Gelder, I.C. van; Schutgens, R.E.G.; Zweedijk, B.; Algra, A.; Dalen, J.W. van; Kappelle, L.J.; Rinkel, G.J.E.; Worp, H.B. van der; Klijn, C.J.M.; APACHE-AF Trial Investigator
- Date
- 2021-11-01
- Journal
- The Lancet Neurology
- Volume
- 20
- Issue
- 11
- Pages
- 907 - 916